Jun 17, 5:03 PM EDT

Netflix, AK Steel, AMD are big movers

Business Video
Buy AP Photo Reprints
Interactives
Greece's Debt Threatens to Spread
State budget
gaps map
Auto industry problems trickle down, punish Tennessee county
Women give old Derby hats a makeover in tough economy
S.C. town deals with highest unemployment in South
How mortgages were bundled and sold as securities
Tracking the $700 billion financial bailout
Tracking the year's job losses
State-by-state foreclosures since 2007
Credit crisis explained
Presidents and their economic legacies
Lexicon of the financial crisis
Americans' addiction to debt
Interactive
Are Stocks Bouncing Back?

NEW YORK (AP) -- Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:

NYSE

Advanced Micro Devices Inc., up 11 cents at $4.05

An article in Barron's said that the chipmaker's stock could rise substantially if its acquisition of SeaMicro is a success.

AK Steel Holding Corp., down 12 cents at $3.45

The steel company said that it will likely post a larger-than-expected second-quarter loss due to higher tax costs.

Nasdaq

Netflix Inc., up $15.24 at $229.23

The online streaming company signed a deal to run original programs from animation studio DreamWorks Animation SKG Inc.

Orchard Supply Hardware Stores Corp., up 23 cents at $2.11

Lowe's Cos. Inc., the home improvement retailer, offered to buy rival Orchard Supply Hardware for about $205 million in cash.

Kandi Technologies Group Inc., up $1.52 at $7.79

The electric vehicle developer said that a Chinese city is building a new vehicle sharing program that will use its vehicles.

Micron Technology Inc., up 48 cents at $13.24

A Citi analyst reiterated that the memory chip maker's stock is on his "Top Pick" list and raised its target price to $19 from $13.50.

Carrizo Oil & Gas Inc., up $1.99 at $28.15

Shares of the energy company rose after the company boosted its oil production guidance for the second quarter.

Synergy Pharmaceuticals Inc., up 16 cents at $4.77

A Citi Investment Research analyst started covering the drug developer's stock with a "Buy" rating based on its constipation drug.

© 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.